Gamblin lab

Structural Biology of Disease Processes Laboratory

 Publications

Structures of proteins investigated in the Gamblin lab

Publications

Year published

Research topics

Publication type

Journal

Displaying 1 - 20 of 50
Last updated : 19 April 2024 02:52

COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history

Authors (37)
PLOS ONE
Published
Crick labs/ facilities
Full details

Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign

Authors (22)
The Lancet
Published
Crick labs/ facilities
Full details

Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants

Authors (26)
PLOS Biology
Published
Crick labs/ facilities
Full details

Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London

Authors (54)
The Lancet
Published
Crick labs/ facilities
Full details

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection

Authors (36)
Lancet Infectious Diseases
Published
Crick labs/ facilities
Full details

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer

Authors (67)
Cancer Cell
Published
Crick labs/ facilities
Full details

O-linked sialoglycans modulate the proteolysis of SARS-CoV-2 spike and likely contribute to the mutational trajectory in variants of concern

Authors (22)
ACS Central Science
Published
Crick labs/ facilities
Full details

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

Authors (64)
Cell Reports Medicine
Published
Crick labs/ facilities
Full details

SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies

Authors (21)
Science Translational Medicine
Published
Crick labs/ facilities
Full details

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

Authors (62)
The Lancet
Published
Crick labs/ facilities
Full details

Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients

Authors (19)
The Lancet
Published
Crick labs/ facilities
Full details

Three-dose vaccination elicits neutralising antibodies against omicron

Authors (26)
The Lancet
Published
Crick labs/ facilities
Full details